Clinical Context
A 52-year-old patient with moderate to severe Crohn disease presents to an outpatient infusion center for maintenance biologic therapy. The clinician has prescribed Q5103 (infliximab-dyyb, biosimilar, Inflectra) 10 mg vial dosing as part of an induction or scheduled maintenance infusion regimen. The patient arrives for pre-infusion nursing assessment, including vital signs, screening for active infections (tuberculosis symptoms review, recent exposure), and review of concomitant immunosuppressive medications.
The clinical workflow: the infusion nurse verifies the physician order and patient identity, documents baseline vitals and allergy history, obtains required pre-infusion labs if indicated (e.g., CBC, CMP), and prepares the biosimilar medication under sterile technique. The medication is administered intravenously per institutional infusion protocol (typically over 2 hours for first infusions, shorter for subsequent infusions if tolerated). During infusion the nurse monitors for infusion reactions (vital signs at regular intervals) and documents medication lot number and expiration. After completion, the patient is observed for a standard recovery period and discharged with follow-up instructions and the next scheduled infusion appointment. Billing uses Q5103 for the dispensed biosimilar product; administration and infusion services are billed separately with the appropriate CPT codes and applicable modifiers.
Coding Specifications
| Modifier | Description | When to Use |
|---|
JW | Drug amount discarded/not administered | Use when a portion of the single-use vial of Q5103 is discarded after preparation and partial dosing. |
| JZ | No drug administered, single-dose vial wasted | Use if the vial is prepared but not administered and cannot be reused.
| 59 | Distinct procedural service | Use when a separate, distinct procedure is performed on the same date as an infusion that is not usually billed with the infusion (e.g., unrelated injection or wound procedure).
| 25 | Significant, separately identifiable E/M service on the same day | Use when an evaluation and management visit is performed on the same day as the infusion that is significant and separately identifiable.
| 24 | Unrelated E/M during postoperative period | Use when an unrelated E/M occurs during a global postoperative period (less commonly applicable but included for E/M context).
| 76 | Repeat procedure by same provider | Use if the same infusion service is repeated by the same provider on the same day (rare for scheduled biologics).
| 78 | Unplanned return to OR by same physician following initial procedure | Generally not applicable to routine infusion but used if patient returns for surgical management related to an infusion complication.
| GA | Waiver of liability statement on file (preauthorization) | Use when an ABN-like waiver is on file for services not covered by a specific payer policy.
| GZ | Service expected to be denied as not reasonable/necessary | Use when billing a payer where the service lacks coverage and no waiver exists.
| AA | Anesthesia services performed personally by anesthesiologist | Use when anesthesia is provided for infusion in rare cases requiring sedation.
| Taxonomy Code | Specialty | Notes |
|---|
207RH0000X | Rheumatology | Rheumatologists commonly prescribe and manage infliximab biosimilars for rheumatoid arthritis, ankylosing spondylitis, and related conditions. |
| 207Q00000X | Gastroenterology | Gastroenterologists commonly prescribe infliximab biosimilars for Crohn disease and ulcerative colitis.
| 363L00000X | Infusion Nurse / Infusion Therapy | Infusion nurses administer IV biologics and manage infusion-related care in outpatient infusion centers.
| 163W00000X | Internal Medicine | Primary care and hospitalists may coordinate and follow patients receiving biologic therapy.
| 207X00000X | Allergy & Immunology | Allergy/immunology specialists may manage biologic therapy for select immune-mediated conditions.
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|
K50.00 | Crohn disease of small intestine without complications | Crohn disease is a common indication for infliximab biosimilars like Q5103 for induction and maintenance therapy. |
| K50.90 | Crohn disease, unspecified, without complications | Used when Crohn disease is documented but site is unspecified; relevant for infliximab therapy.
| K51.90 | Ulcerative colitis, unspecified, without complications | Ulcerative colitis is another inflammatory bowel disease indication treated with infliximab biosimilars.
| M05.79 | Rheumatoid arthritis with rheumatoid factor, multiple sites | Rheumatoid arthritis is an FDA-approved indication for infliximab-class biologics.
| M06.9 | Rheumatoid arthritis, unspecified | Used when RA is documented without further specificity; infliximab biosimilars may be used for moderate to severe disease.
| M45.9 | Ankylosing spondylitis, unspecified | Ankylosing spondylitis is an inflammatory spondyloarthritis treated with TNF inhibitors including infliximab biosimilars.
| L40.54 | Psoriatic juvenile arthropathy | Psoriatic arthritis is an indication treated with TNF inhibitor biologics; infliximab may be used in adult forms as well.
| B20 | Human immunodeficiency virus [HIV] disease | Not an indication for infliximab; included here to prompt screening for active infections prior to immunosuppressive therapy.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
96413 | Chemotherapy administration, IV infusion technique; up to 1 hour, single or initial substance/drug | Used for billing the infusion administration time for biologic IV infusions when infusion duration fits the code definition. |
| 96415 | Chemotherapy administration, each additional hour | Used when the infusion extends beyond the initial hour and additional hourly units are required for billing administration time.
| 96365 | Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour | An alternative administration code used in some outpatient infusion settings for non-chemotherapy biologic infusions.
| 96366 | Each additional hour (for 96365) | Used when the infusion extends beyond the initial hour under 96365.
| 99406 | Tobacco use cessation counseling, intermediate, 3-10 minutes | Example of an add-on E/M counseling code that may be billed if counseling is provided during the visit (use of same-day E/M modifiers as appropriate).
| 36415 | Collection of venous blood by venipuncture | Used for pre-infusion laboratory draws required before or during an infusion visit.